Group Music Therapy for Acquired Brain Injury
Launched by UNIVERSITY OF VALENCIA · Mar 26, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how group music therapy can help patients with acquired brain injuries (ABI) feel more comfortable and improve their overall well-being. The researchers want to see if a specific music therapy program can help these patients adjust better to their condition and work alongside their regular medical treatments. The study is currently looking for participants, and it will involve assessing patients before and after they take part in the music therapy sessions.
To be eligible for this trial, participants need to be adults over 18 years old who have been hospitalized for at least a week due to a sudden brain injury. They should have experienced changes in their physical, mental, or emotional abilities but should still be stable enough to participate in rehabilitation. Importantly, they should have been functioning well before their injury. If someone joins the study, they can expect to take part in group music therapy sessions that aim to support their healing journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with acquired brain damage who has been admitted to the hospital for at least one week. The patient has experienced a sudden brain injury resulting in physical, psychological, cognitive, behavioural or sensory deficits that have reduced their previous functional capacity and quality of life. The patient is clinically stable enough to undergo rehabilitation and had a good functional situation prior to the episode (Barthel Index \> 60).
- • Be over 18 years of age.
- • The participant or their relatives have signed the informed consent form.
- • They have completed the group music therapy intervention session, as well as the pre-test and post-test evaluations.
- Exclusion Criteria:
- • Failure to obtain informed consent
- • The Barthel Index score is below 60, indicating functional dependency.
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Serra, Valencia, Spain
Patients applied
Trial Officials
Marián Pérez-Marín, PhD
Principal Investigator
University of Valencia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported